Skip to main content
Premium Trial:

Request an Annual Quote

Caprion and ICOS Sign Protein Biomarker-Discovery Deal

NEW YORK, Jan. 18 (GenomeWeb News) - Caprion Pharmaceuticals said today that it will collaborate with ICOS to identify pharmacodynamic markers in plasma using its CellCarta proteomics platform.

 

Bothell, Wash.-based ICOS will use the research in its preclinical oncology programs, according to a statement.

 

The agreement builds upon a collaboration that Caprion and ICOS entered last March related to tumor antigen target discovery.

 

Financial details of the agreement were not disclosed.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.